HubMed
HubMed provides an AI-assisted platform that unifies in-silico compound discovery with regulatory compliance for nutraceutical, cosmetic, and medical device companies. The platform integrates two engines—Adam™ for molecular design and Medea™ for clinical evaluation—to reduce time-to-market by up to 70% while keeping experts in control through source-tethered, audit-ready evidence.
- Artificial Intelligence
- Regulatory & Compliance Technology
- Biotechnology
- Healthcare Technology
- Software Only
- Data & Analytics
- Hardware
- Medical Devices
Funding
Founders
Founder details are not available yet.
Product
Problem
R&D teams in specialized life sciences face significant bottlenecks due to fragmented workflows between initial compound discovery and final regulatory audit-readiness. Manual molecule ideation and overwhelming volumes of scientific literature slow down innovation and delay market access, particularly for nutraceutical, cosmetic, and medical device companies navigating complex compliance landscapes.
Solution
HubMed provides a unified AI ecosystem that automates high-value scientific processes, integrating in-silico compound discovery with clinical evaluation and post-market surveillance. The platform machine-reads thousands of scientific publications to distill actionable evidence, using the PICO framework to ensure every insight is structured, traceable, and ready for Notified Body audits. By combining these capabilities, HubMed bridges the gap from lab to market, reducing time-to-market by up to 70% and enabling teams to move from manual ideation to evidence-based decision-making. The platform also automates post-market surveillance and Clinical Evaluation Report (CER) generation, keeping experts in control through human-verifiable, source-tethered outputs.
Target Audience
Primary customers are R&D teams in the nutraceutical, cosmetic, and medical device sectors, as well as Contract Research Organizations (CROs) seeking to enhance operational efficiency, profitability, and audit-readiness.
Features
- Integrated AI ecosystem combining two core modules: Adam™ for in-silico compound discovery (automating molecular design and candidate screening 10x faster) and Medea™ for clinical evaluation and regulatory documentation (cutting CER drafting and literature appraisal time by up to 70%)
- Machine-reading engine that processes thousands of scientific publications to extract structured, actionable evidence
- PICO framework implementation ensuring every insight is traceable and audit-ready for Notified Body compliance
- Industry-specific solutions for nutraceuticals (bioactive identification and health claim validation), cosmetics (in-silico safety profiling), medical devices (MDR/IVDR pathways), and CROs (operational efficiency and NB-ready documentation)
- Automated post-market surveillance and Clinical Evaluation Report (CER) generation for streamlined regulatory pathways
- End-to-end integration from discovery through documentation, eliminating the fragmentation gap between research and compliance